Concepedia

Ravaen Slay

RS

3

Publications

300

Citations

3

H-Index

2019

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Ravaen Slay is an author at The University of Texas MD Anderson Cancer Center specializing in tumor immunity, t cell immunity, and immune regulation.

Top concepts

Publications per year

2019–2022

3

Publications

3

ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer

Cheng‐En Hsieh, Sunil Krishnan, Ren‐Chin Wu et al. · Science Immunology · 2022 · 140 citations · Full text

, , +17

Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer

Stephanie Dorta‐Estremera, Venkatesh L. Hegde, Ravaen Slay et al. · Journal for ImmunoTherapy of Cancer · 2019 · 95 citations · Full text

High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege

Casey R. Ager, Akash R. Boda, Kimal Rajapakshe et al. · Journal for ImmunoTherapy of Cancer · 2021 · 65 citations · Full text

Rows per page

1–3 of 3